AARD vs HUBS · $284.4M cap vs P/E 96, rev $1.79B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
AARD currently screens at market cap $284.4M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the AARD and HUBS stock pages for the full models.
Not investment advice.